Clinical Trial Detail

NCT ID NCT03784378
Title Continued Access to RXDX-105
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

lung non-small cell carcinoma

ovarian cancer

Therapies

RXDX-105

Age Groups: adult senior

Additional content available in CKB BOOST